Infant RSV Hospital Admissions Drop Sharply After Vaccine Rollout in Denmark
Source Summary
Since fall 2025, pregnant women in Denmark have been offered an RSV vaccine to protect their infants during early life. RSV causes severe breathing difficulties in newborns and young infants and can require hospitalization. Hospital admissions for RSV among infants have fallen sharply following the vaccine rollout.
Why it matters
The sharp decline in infant RSV hospitalizations demonstrates the vaccine's effectiveness in preventing severe disease in newborns and young infants.
